CohBar, Inc. (CWBR)
NASDAQ: CWBR · IEX Real-Time Price · USD
2.70
-0.09 (-3.23%)
At close:
May 26, 2023, 4:00 PM
2.84
+0.14 (5.19%)
Pre-market:
May 30, 2023, 4:23 AM EDT
CohBar Market Cap
CohBar has a market cap or net worth of $7.85 million as of May 30, 2023. Its market cap has decreased by -55.91% in one year.
Market Cap
7.85M
Enterprise Value
-6.23M
1-Year Change
-55.91%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since December 18, 2017, CohBar's market cap has decreased from $210.80M to $7.85M, a decrease of -96.28%. That is a compound annual growth rate of -45.40%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 26, 2023 | 7.80M | -3.70% |
May 25, 2023 | 8.10M | -22.86% |
May 24, 2023 | 10.50M | -28.08% |
May 23, 2023 | 14.60M | 224.44% |
May 22, 2023 | 4.50M | -6.25% |
May 19, 2023 | 4.80M | 4.35% |
May 18, 2023 | 4.60M | 4.55% |
May 17, 2023 | 4.40M | -2.22% |
May 16, 2023 | 4.50M | - |
May 15, 2023 | 4.50M | -2.17% |
May 12, 2023 | 4.60M | - |
May 11, 2023 | 4.60M | -6.12% |
May 10, 2023 | 4.90M | - |
May 9, 2023 | 4.90M | -3.92% |
May 8, 2023 | 5.10M | 4.08% |
May 5, 2023 | 4.90M | -2.00% |
May 4, 2023 | 5.00M | -1.96% |
May 3, 2023 | 5.10M | 4.08% |
May 2, 2023 | 4.90M | -3.92% |
May 1, 2023 | 5.10M | - |
Apr 28, 2023 | 5.10M | - |
Apr 27, 2023 | 5.10M | - |
Apr 26, 2023 | 5.10M | - |
Apr 25, 2023 | 5.10M | -1.92% |
Apr 24, 2023 | 5.20M | -5.45% |
View and export this data all the way back to 2017.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Minerva Neurosciences, Inc. | 33.24M |
PetVivo Holdings, Inc. | 24.66M |
NeuroSense Therapeutics Ltd. | 18.88M |
Aprea Therapeutics, Inc. | 12.69M |
Sonnet BioTherapeutics Holdings, Inc. | 11.81M |
Virpax Pharmaceuticals, Inc. | 9.26M |
Exicure, Inc. | 7.13M |
Artelo Biosciences, Inc. | 4.83M |
Motus GI Holdings, Inc. | 3.87M |